Radar > 238112

Ourofino announces Kleber Cesar Silveira Gomes as new Director of Investors Relations

A Ourofino anuncia a Kleber Cesar Silveira Gomes como novo Diretor de Relações com Investidores

Intel ID : 238112
Synopsis

Ourofino (BVMF:OFSA3), a manufacturer and distributor of veterinarian pharmaceutical products based in São Paulo, announced the appointment of Kleber Cesar Silveira Gomes as its new Director of Investors Relations, as published by the company through a press release on 27 June 2016.

Kleber Cesar Silveira Gomes will replace Fábio Lopes Júnior, who resigned.
(content in portuguese)

A Ourofino (BVMF:OFSA3), empresa com sede em São Paulo que se dedica à fabricação e distribuição produtos farmacêuticos veterinários, anunciou a Kleber Cesar Silveira Gomes como novo Diretor de Relações com Investidores, segundo publicou a empresa em Comunicado no dia 27 de junho de 2016.

O executivo Kleber Cesar Silveira Gomes vai substituir a Fábio Lopes Júnior que renunciou ao cargo.

Relevant Documents

Target


Intel ID 238112
Value ND
Native Currency Brazilian Real (BRL)
Exchange Rate:
Financial Data - Ourofino
(31 Dec 2024)
Revenue: EUR 159,98m
EBITDA: EUR 35,05m
Net Debt: EUR 19,58m
Exchange Rate:
Date
Country
Region
Continent
Geography
Subsector (Old TTR Sectors)
Type
Intel Grade
Source
Tags

Target

Name
verified
Subsector (Old TTR Sectors)
Industry / Pharmaceutical, Parapharmaceutical and Cosmetics (Primary)
Services and Distribution / Financial and Insurance
Primary Sector (TTRSC)
15.09.02 Pet Food & Pet Supplies Manufacturing
15 Consumer Products & Services / 15.09 Pet Products & Services

Country
Website
Description

Legend:

verified Verified: Confirmed as a party to an active or possible transaction.

potential Potential: Unconfirmed as a party to an active or possible transaction.

retained Retained: Confirmed as “Retained” with a general or specific mandate.

prospect Prospect: Advisory “Prospect” in discussions with or pitching services to possible client.

Transactional data is continuously updated by the research team and therefore is subject to change.